Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Descemet Stripping Only in Fuchs Endothelial Corneal Dystrophy: Results of a Randomized Clinical Trial of Topical Ripasudil and Directions for Future Innovation.

American journal of ophthalmology·2026
Same author

Intermediate Term Results of a Novel Minimally Invasive Keratoprosthesis.

Ophthalmology science·2026
Same author

Gender-Based Salary Disparities in Ophthalmology-Seeing the Pay Gap.

JAMA ophthalmology·2026
Same author

Corneal Endothelial Keratoplasty After Glaucoma Treatment: An American Academy of Ophthalmology IRIS® Registry Analysis.

Ophthalmology. Glaucoma·2026
Same author

Stromal Keratitis in the Zoster Eye Disease Study: Lessons Learned.

American journal of ophthalmology·2026
Same author

Delphi-Based Global Consensus on Fuchs Endothelial Corneal Dystrophy. An Endothelial Keratoplasty Learners Group Initiative.

American journal of ophthalmology·2025

Related Experiment Video

Updated: Jun 6, 2026

Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis
07:29

Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis

Published on: November 12, 2015

Corneal cross linking for keratoconus.

Anne Keating1, Roberto Pineda, Kathryn Colby

  • 1Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, USA. keat0026@gmail.com

Seminars in Ophthalmology
|November 25, 2010
PubMed
Summary
This summary is machine-generated.

Riboflavin-induced ultraviolet light (UV) crosslinking is a safe and effective treatment for early keratoconus. This review examines key studies supporting its use in corneal disorders.

More Related Videos

Second Harmonic Generation Signals in Rabbit Sclera As a Tool for Evaluation of Therapeutic Tissue Cross-linking (TXL) for Myopia
12:25

Second Harmonic Generation Signals in Rabbit Sclera As a Tool for Evaluation of Therapeutic Tissue Cross-linking (TXL) for Myopia

Published on: January 6, 2018

Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model
05:56

Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model

Published on: April 3, 2016

Related Experiment Videos

Last Updated: Jun 6, 2026

Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis
07:29

Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis

Published on: November 12, 2015

Second Harmonic Generation Signals in Rabbit Sclera As a Tool for Evaluation of Therapeutic Tissue Cross-linking (TXL) for Myopia
12:25

Second Harmonic Generation Signals in Rabbit Sclera As a Tool for Evaluation of Therapeutic Tissue Cross-linking (TXL) for Myopia

Published on: January 6, 2018

Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model
05:56

Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model

Published on: April 3, 2016

Area of Science:

  • Ophthalmology
  • Corneal Science
  • Biomedical Engineering

Background:

  • Keratoconus is a progressive corneal disorder.
  • Current treatments for keratoconus have limitations.
  • Riboflavin-induced ultraviolet light (UV) crosslinking has emerged as a promising therapeutic option.

Purpose of the Study:

  • To review seminal papers and studies on riboflavin-induced UV crosslinking.
  • To evaluate the safety and efficacy of crosslinking for early keratoconus.
  • To provide a comprehensive overview of the evidence supporting this treatment.

Main Methods:

  • Literature review of key studies and seminal papers.
  • Analysis of research supporting crosslinking for keratoconus.
  • Synthesis of data on safety and efficacy.

Main Results:

  • Crosslinking has demonstrated significant potential in treating keratoconus.
  • Studies support its safety and effectiveness in early-stage disease.
  • Approved in Europe, it's increasingly used for various corneal conditions.

Conclusions:

  • Riboflavin-induced UV crosslinking is a well-supported treatment for early keratoconus.
  • The reviewed literature confirms its safety and efficacy.
  • Further research may expand its applications in ophthalmology.